Abderezak Zebboudj

42 posts

Abderezak Zebboudj

Abderezak Zebboudj

@A_Zebboudj

PhD, Postdoc| cancer immunology @TheVinodLab, @MSKCancerCenter

Manhattan, NY Katılım Mart 2013
191 Takip Edilen70 Takipçiler
Abderezak Zebboudj retweetledi
Pablo Guasp
Pablo Guasp@PabloGuasp·
I am excited to share our new work on personalized mRNA vaccines in pancreatic cancer in @Nature: nature.com/articles/s4158… Great thread below by @TheVinodLab explaining the findings. As always, it is a pleasure to be part of this team with such great colleagues and friends.
English
5
22
77
8.2K
Abderezak Zebboudj retweetledi
CBS News
CBS News@CBSNews·
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients. cbsn.ws/3ELPY2y
English
25
51
150
42.7K
Abderezak Zebboudj retweetledi
nature
nature@Nature·
The bidirectional transfer of mitochondria between cancer and immune cells is a newly discovered mechanism that thwarts anticancer defences go.nature.com/3WyCUnb
English
26
231
835
59.2K
Abderezak Zebboudj retweetledi
nature
nature@Nature·
Nature research paper: IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer go.nature.com/4alg9c5
English
1
13
56
16.1K
Abderezak Zebboudj retweetledi
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center@MSKCancerCenter·
A research team led by @TheVinodLab, a surgeon-scientist and director of the Olayan Center for Cancer Vaccines at MSK, has made new insights into how the body forms immune cell clusters called tertiary lymphoid structures (TLSs) in response to cancer. In the study published in
Memorial Sloan Kettering Cancer Center tweet media
English
2
9
74
7.8K
Abderezak Zebboudj
Abderezak Zebboudj@A_Zebboudj·
I am thrilled to see our latest findings out in @Nature -we identify that IL33 induces Tertiary Lymphoid structure via ILC2s. -we show that this pathway is druggable and engineered human rIL33 as potentially a novel immunotherapy! I am glad to have led this study with @m_amisaki and @TheVinodLab
Vinod BalachandranMD@TheVinodLab

1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity   But how? What molecule triggers? What cells induce?   TODAY in @Nature nature.com/articles/s4158…   Long-term #PDAC survivor PART4 – TLSs   🧵1/25

English
2
4
30
3K
Abderezak Zebboudj retweetledi
Anirban Maitra
Anirban Maitra@Aiims1742·
New @Nature paper from @TheVinodLab @MSKCancerCenter on the role of interleukin IL-33 inducing tertiary lymphoid structures (TLS) in #PancreaticCancer The alarmin domain of IL-33 binds to its cognate receptor and attracts ILC2 from the gut to the tumor milieu and induces TLS
Anirban Maitra tweet media
English
1
21
95
6.4K
Abderezak Zebboudj retweetledi
Vinod BalachandranMD
Vinod BalachandranMD@TheVinodLab·
1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity   But how? What molecule triggers? What cells induce?   TODAY in @Nature nature.com/articles/s4158…   Long-term #PDAC survivor PART4 – TLSs   🧵1/25
English
6
62
215
27.6K
Abderezak Zebboudj retweetledi
Gabrielle Rizzuto
Gabrielle Rizzuto@GlycoGabi·
Recruiting a postdoc to study mechanisms of tolerance & immunity in the pregnant host. If you are passionate about this understudied area and excited to discover mechanisms of humoral tolerance to the placenta & fetus, do get in touch. (1/2)
English
1
66
134
25.7K
Abderezak Zebboudj retweetledi
Pablo Guasp
Pablo Guasp@PabloGuasp·
Exciting times for cancer vaccines as mRNA leads the charge! Insights from vaccines against pathogens pave the way for personalized cancer vaccination. @CharReiche, Zachary Sethna, @TheVinodLab, and myself discuss this and much more in our newly published review in @Cancer_Cell
English
1
5
14
3.4K

Keşfet

@Nature @TheVinodLab @PabloGuasp @MSKCancerCenter @m_amisaki @HiroTheHero_PhD @Martina_Milig @bengrbm